Intro

This chapter explores serious accusations against a tech executive for allegedly using server access to obtain compromising information on Donald Trump. It also delves into the political ramifications of these claims and recent polling data reflecting Democratic hesitance towards Biden's re-election, while addressing the FDA's position on drug approvals from China.